DNA vaccination against neu reduces breast cancer incidence and metastasis in mice (Q40800991)

23 September 2017

title

DNA vaccination against neu reduces breast cancer incidence and metastasis in mice (English)

1 reference

23 September 2017

Lachman LB

1 reference

23 September 2017

Rao XM

1 reference

23 September 2017

Kremer RH

1 reference

23 September 2017

Ozpolat B

1 reference

23 September 2017

Kiriakova G

1 reference

23 September 2017

Price JE

1 reference

23 September 2017

publication date

1 April 2001

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

259-268

1 reference

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Live virus vaccines: something old, something new, something borrowed...

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Genetic immunization: a new era in vaccines and immune therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700300

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700300

1 reference

Dimensions Publication ID

23 September 2017

1022476706

0 references

1 reference